Drug intelligence / Profile preview

UltraFree DCB

Development stage
Preclinical
Lead developer
Zylox-Tonbridge
Administration
Intravascular
01

Overview

UltraFree DCB is a drug-coated balloon (DCB) catheter used in percutaneous transluminal angioplasty procedures, typically for the treatment of arterial stenosis. It features the proprietary UltraFree coating, designed to minimize early drug flaking during preparation and track, ensuring quick and controlled drug release to the vessel wall. The primary active pharmaceutical ingredient is likely paclitaxel, consistent with standard DCB technologies, although exact drug content is not stated in the available sources. The device is primarily indicated for use in the management of peripheral or coronary artery disease, targeting vessel restenosis or de novo lesions, with the goal of inhibiting neointimal hyperplasia and reducing rates of repeat revascularization.

Brand names
UltraFree DCB
Other names
UltraFree DCB
02

Targets

TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on UltraFree DCB.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UltraFree DCB.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call